[ad_1]
COMIRNATY, developed by Pfizer and BioNTech, was the first conditionally licensed anti-COVID-19 vaccine in the European Union to be used to actively immunize a population 16 years of age or older to prevent COVID-19 infection from the SARS-CoV virus -two. .countries.
The first shipment arrived in Hungary on December 26, 2020, followed by reliable weekly doses of vaccine to help fight the coronavirus. Together with the new doses received on March 23, the number of vaccine doses delivered to Hungary exceeded 1.2 million doses, which is enough to vaccinate more than 640,000 people twice.
The two companies focused on strengthening and expanding their production capabilities in early 2021, aiming to produce and ship more than 2 billion doses of the COVID-19 vaccine worldwide this year to meet growing global demand. .
In the case of Hungary, Pfizer reliably delivered the total amount of vaccine made during the first quarter and, starting in the second quarter of 2021, it will significantly increase the number of vaccine doses delivered to the country.
Cover image: Getty Images
[ad_2]
